نتایج جستجو برای: پروبیوتیک abt 10

تعداد نتایج: 1019339  

2016
Michelle A. Rudek Arvind Dasari Daniel Laheru Ping He Runyan Jin Rosalind Walker Gretchen E. Taylor Antonio Jimeno Ross C. Donehower Manuel Hidalgo Wells A. Messersmith W. Thomas Purcell

ABT-751 is an orally bioavailable sulfonamide with antimitotic properties. A nonrandomized phase 1 dose-escalation study of ABT-751 in combination with CAPIRI (capecitabine and irinotecan) and bevacizumab was conducted to define the maximum tolerated dose, dose-limiting toxicity (DLT), and pharmacokinetics in patients with advanced colorectal cancer. Patients were treated with ABT-751 daily for...

2010
T. Lam Xin Lu Haichao Zhang Rick Lesniewski Dimitri Semizarov

ownload sion of apoptosis is a known feature of cancer cells. One mechanism of deregulating the apoptotic paththrough overexpression of antiapoptotic BCL2 family members. ABT-263 (navitoclax) is a first-in-class family inhibitor that restores the ability of cancer cells to undergo apoptosis. However, many cancer re resistant to ABT-263 due to high levels of a BCL2 family member, MCL1, which is ...

Journal: :Journal of Applied Electrochemistry 2022

Abstract The inhibitive action of 2-aminobenzothiazole (ABT) on the corrosion AA6061-T6 was evaluated in 0.5 M HCl by electrochemical techniques. results were validated theoretical calculations using density functional theory (DFT). ABT showed a mixed inhibitor behaviour with 71–90% inhibition efficiency 1 × 10 ?4 to ?3 concentration range and at 303 323 K temperature. power increases its rise ...

Journal: :International Journal of Social Science 2023

The aim of this research were investigated bamboo-based activated charcoal (ABT)characteristics using Scanning Electron Microscopy (SEM) and Fourier Transform Infrared (FTIR). ABT has been successfully synthesized through physico-chemical activation at 700°C with H3PO4 10% solution as activator. resulted porous surface structure bamboo causes an absorption interaction pollutants (cations, anion...

2016
Yoshifumi Tada Nobuyuki Ono Rie Suematsu Satoko Tashiro Yuri Sadanaga Yukiko Tokuda Yukihide Ono Yoshinobu Nakao Akihito Maruyama Akihide Ohta Syuichi Koarada

BACKGROUND The balance between Th17 cells and regulatory T (Treg) cells has been shown to play an important role in the development of rheumatoid arthritis (RA). Recent studies have shown that treatment with abatacept (ABT) or tocilizumab (TCZ) affects Th17 and Treg cell populations. Although not unanimously accepted, several reports have shown that Treg cells are decreased by ABT and increased...

Journal: :Vox sanguinis 2014
M Muñoz D Iglesias J A Garcia-Erce J Cuenca A Herrera E Martin-Montañez J Pavia

BACKGROUND Postoperative blood loss may be a risk factor for allogeneic blood transfusion (ABT) in patients undergoing subcapital hip fracture (SHF) repair. We investigated the utility and costs of using a low-vacuum reinfusion drain (Bellovac ABT) within a blood management protocol for reducing ABT requirements in consecutive SHF. METHODS The blood management protocol consisted of the applic...

Journal: :Cancer research 2008
Christin Tse Alexander R Shoemaker Jessica Adickes Mark G Anderson Jun Chen Sha Jin Eric F Johnson Kennan C Marsh Michael J Mitten Paul Nimmer Lisa Roberts Stephen K Tahir Yu Xiao Xiufen Yang Haichao Zhang Stephen Fesik Saul H Rosenberg Steven W Elmore

Overexpression of the prosurvival Bcl-2 family members (Bcl-2, Bcl-xL, and Mcl-1) is commonly associated with tumor maintenance, progression, and chemoresistance. We previously reported the discovery of ABT-737, a potent, small-molecule Bcl-2 family protein inhibitor. A major limitation of ABT-737 is that it is not orally bioavailable, which would limit chronic single agent therapy and flexibil...

Journal: :Drug metabolism and disposition: the biological fate of chemicals 2009
Collette D Linder Nicole A Renaud J Matthew Hutzler

1-Aminobenzotriazole (1-ABT) is generally considered to be a nonselective mechanism-based inactivator of both human and non-human cytochrome P450 (P450) enzymes. Thus, 1-ABT is routinely used when conducting in vitro reaction phenotyping studies with new chemical entities in drug discovery to decipher P450 from non-P450-mediated metabolism. Experiments with pooled human liver microsomes (HLMs) ...

2011
Xiangxuan Zhao Olorunseun O. Ogunwobi Chen Liu

Our study aims to study the therapeutic effects of a novel Bcl-2 inhibitor, ABT-263, on hepatocellular carcinoma (HCC) and to provide primary preclinical data for future clinical trial with ABT-263. In this study we showed that Bcl-xL and survivin were up-regulated in HCC cell lines and human liver cancer tissues. Clinic used ABT-263 single treatment had no apoptotic effects on HCC cells wherea...

Journal: :Cancer discovery 2014
Rongqing Pan Leah J Hogdal Juliana M Benito Donna Bucci Lina Han Gautam Borthakur Jorge Cortes Daniel J DeAngelo Lakeisha Debose Hong Mu Hartmut Döhner Verena I Gaidzik Ilene Galinsky Leonard S Golfman Torsten Haferlach Karine G Harutyunyan Jianhua Hu Joel D Leverson Guido Marcucci Markus Müschen Rachel Newman Eugene Park Peter P Ruvolo Vivian Ruvolo Jeremy Ryan Sonja Schindela Patrick Zweidler-McKay Richard M Stone Hagop Kantarjian Michael Andreeff Marina Konopleva Anthony G Letai

B-cell leukemia/lymphoma 2 (BCL-2) prevents commitment to programmed cell death at the mitochondrion. It remains a challenge to identify those tumors that are best treated by inhibition of BCL-2. Here, we demonstrate that acute myeloid leukemia (AML) cell lines, primary patient samples, and murine primary xenografts are very sensitive to treatment with the selective BCL-2 antagonist ABT-199. In...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید